Kamil Biringer - Gynecology

Author Information

Kamil Biringer is a prominent researcher affiliated with the Clinic of Obstetrics and Gynecology at the Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia. His work primarily focuses on various aspects of gynecology, including breast cancer, cervical microbiome, preeclampsia, and more.

Research Contributions

Kamil Biringer has made significant contributions to the field of gynecology through his extensive research. His work spans the exploration of anti-breast cancer effects of phytochemicals, interaction of cervical microbiome with epithelial cells' epigenome, and the interplay between the vaginal microbiome and innate immunity. He has also conducted studies on the association of circulating miRNA expression with preeclampsia, the protective effects of flavonoids, and the health risks associated with "normal" BMI. His recent research also includes targeting phytoprotection in COVID-19-induced lung damage, and examining metabolic anti-cancer effects of melatonin.

Aliases

Kamil Biringer is also known by the aliases K Biringer and K. Biringer.

Publication and Citation Metrics

Metric	Value
Citation Count	965
H-Index	19
Paper Count	81

Publications:

Anti-breast cancer effects of phytochemicals: primary, secondary, and tertiary care

DOI: 10.1007/s13167-022-00277-2

Year: 2022

Interaction of cervical microbiome with epigenome of epithelial cells: Significance of inflammation to primary healthcare

DOI: 10.1515/bmc-2022-0005

Year: 2022

The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer

DOI: 10.1007/s13167-021-00244-3

Year: 2021

Association of Circulating miRNA Expression with Preeclampsia, Its Onset, and Severity

DOI: 10.3390/diagnostics11030476

Year: 2021

Protective Effects of Flavonoids Against Mitochondriopathies and Associated Pathologies: Focus on the Predictive Approach and Personalized Prevention

DOI: 10.3390/ijms22168649

Year: 2021

Caution, “normal” BMI: health risks associated with potentially masked individual underweight—EPMA Position Paper 2021

DOI: 10.1007/s13167-021-00251-4

Year: 2021

Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects—the evidence-based 3PM proposition to mitigate individual risks

DOI: 10.1007/s13167-021-00249-y

Year: 2021

Recurrent Giant Malignant Phyllodes Tumor of the Breast

DOI: 10.1155/2021/2476691

Year: 2021

Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person

DOI: 10.1007/s13167-021-00263-0

Year: 2021

Metabolic Anti-Cancer Effects of Melatonin: Clinically Relevant Prospects

DOI: 10.3390/cancers13123018

Year: 2021

What Should Gynecologists Do When They Suspect Domestic Violence?

How can diet help manage common gynecological conditions?

What is Fertility Awareness?

How Are Thyroid Function Tests Relevant?

How Do Gynecological Cancers Affect Mental Health?

What is a Postpartum Doula?

Why is a history of drug or alcohol abuse important in gynecology?

Why is Emotional Adjustment Important?

What Resources Are Available for Women’s Gynecological Health?

What Are Some Preventive Measures?

Partnered Content Networks

Relevant Topics